| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |